Cyclerion Therapeutics
CYCN
CYCN
73 hedge funds and large institutions have $66.9M invested in Cyclerion Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
52% less capital invested
Capital invested by funds: $140M → $66.9M (-$72.7M)
63% less call options, than puts
Call options by funds: $21K | Put options by funds: $57K
Holders
73
Holding in Top 10
–
Calls
$21K
Puts
$57K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$330K | |
| 3 | +$314K | |
| 4 |
D.E. Shaw & Co
New York
|
+$256K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$247K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$3.48M | |
| 3 | -$420K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$272K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$240K |